Research outputs
2025
406 Risk-Stratified Secondary Surveillance for Individuals in the UK at High Risk of Developing Pancreatic Cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC)
Hopley, P., Peysner, R., Boughey, A., Kewlani, B., Smith, A., Aithal, G., . . . Halloran, C. (2025). 406 Risk-Stratified Secondary Surveillance for Individuals in the UK at High Risk of Developing Pancreatic Cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC). British Journal of Surgery, 112(Supplement_17). doi:10.1093/bjs/znaf270.041
Association of ELAC2 mutation with Familal Pancreatic Cancer
Greenhalf, W., Halloran, C., Bullock, K., Thomas, P., Hopley, P., Boughey, A., . . . Campa, D. (2025). Association of ELAC2 mutation with Familal Pancreatic Cancer. Pancreatology, 25(7), 1305. doi:10.1016/j.pan.2025.07.202
European Registry of Hereditary Pancreatic Diseases (EUROPAC): protocol for primary and secondary screening in individuals with inherited pancreatic disease syndromes for pancreatic ductal adenocarcinoma and complications of other pancreatic diseases.
Boughey, A., Hopley, P., Sarantitis, I., Thomas, P., Gubacsi, B., Jevons, K., . . . Halloran, C. (2025). European Registry of Hereditary Pancreatic Diseases (EUROPAC): protocol for primary and secondary screening in individuals with inherited pancreatic disease syndromes for pancreatic ductal adenocarcinoma and complications of other pancreatic diseases.. BMJ open, 15(4), e100027. doi:10.1136/bmjopen-2025-100027
2024
Classification of families with multiple pancreatic cancer cases, based on shared polymorphisms in cancer related genes, indicates susceptibility to potentially pathogenic germline variants
Sheel, A., Bullock, K., Hopley, P., Boughey, A., Hanson, H., Hughes, E., . . . Greenhalf, W. (2024). Classification of families with multiple pancreatic cancer cases, based on shared polymorphisms in cancer related genes, indicates susceptibility to potentially pathogenic germline variants. Pancreatology, 24, e24. doi:10.1016/j.pan.2024.05.055
2023
Characteristics of BRCA2 families in a familial pancreatic cancer registry
Hopley, P., Downes, J., Law, J., Boughey, A., Halloran, C., & Greenhalf, W. (2023). Characteristics of BRCA2 families in a familial pancreatic cancer registry. Pancreatology, 23, e30-e31. doi:10.1016/j.pan.2023.06.479
2021
Context specific differences in BRCA2 associated cancer risk
Law, J., Hopley, P., Sarantitis, I., Boughey, A., Pereira, S., Costello, E., . . . Greenhalf, W. (2021). Context specific differences in BRCA2 associated cancer risk. Pancreatology, 21, S62. doi:10.1016/j.pan.2021.05.163
How the COVID-19 pandemic has impacted participation of a pancreatic cancer screening programme
Hopley, P., Sarantitis, I., Edgington, O., Boughey, A., Halloran, C., & Greenhalf, W. (2021). How the COVID-19 pandemic has impacted participation of a pancreatic cancer screening programme. Pancreatology, 21, S81. doi:10.1016/j.pan.2021.05.220